Staphylococcus aureus bacteremia: the cost-effectiveness of long-term therapy associated with infectious diseases consultation.

Clinical performance and quality health care

Volumn 6, Issue 1, 1998, Pages 9-11

  Lundberg, J ^a   Nettleman, M D ^a   Costigan, M ^a   Bentler, S ^a   Dawson, J ^a   Wenzel, R P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BACTEREMIA; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DRUG COST; ECONOMICS; FEMALE; HOSPITAL BED CAPACITY; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATIENT REFERRAL; SOCIOECONOMICS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TEACHING HOSPITAL; TIME; TREATMENT OUTCOME; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTEREMIA; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG COSTS; FEMALE; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, TEACHING; HUMANS; IOWA; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS; TREATMENT OUTCOME; VALUE OF LIFE;

EID: 0031599720     PISSN: 10630279     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)